Informations:
Erreur:
ID
16223
Description
Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00146601
Lien
https://clinicaltrials.gov/show/NCT00146601
Mots-clés
Versions (1)
- 06/07/2016 06/07/2016 -
Téléchargé le
6 juillet 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT00146601
Eligibility Breast Cancer NCT00146601
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00146601
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Invasive carcinoma of breast | Stage level 4
Item
histologically or cytologically confirmed invasive breast cancer, with stage iv disease.
boolean
C0853879 (UMLS CUI [1])
C0441772 (UMLS CUI [2])
C0441772 (UMLS CUI [2])
Estrogen receptor positive | progesterone receptor positive | Estrogen receptor positive progesterone receptor positive
Item
tumors must be positive for estrogen receptors, progesterone receptors, or both.
boolean
C0279754 (UMLS CUI [1])
C0279759 (UMLS CUI [2])
C0279754 (UMLS CUI [3,1])
C0279759 (UMLS CUI [3,2])
C0279759 (UMLS CUI [2])
C0279754 (UMLS CUI [3,1])
C0279759 (UMLS CUI [3,2])
Premenopausal
Item
patients must be premenopausal.
boolean
C0279752 (UMLS CUI [1])
Antioestrogen therapy | Ovarian suppression | Antioestrogen therapy Ovarian suppression
Item
prior anti-estrogen therapy (with or without ovarian suppression)
boolean
C0854638 (UMLS CUI [1])
C0677922 (UMLS CUI [2])
C0854638 (UMLS CUI [3,1])
C0677922 (UMLS CUI [3,2])
C0677922 (UMLS CUI [2])
C0854638 (UMLS CUI [3,1])
C0677922 (UMLS CUI [3,2])
Platelet Count measurement
Item
platelet count > 100,000/mm3
boolean
C0032181 (UMLS CUI [1])
Age
Item
age older than 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Hormone Therapy Metastatic Neoplasm
Item
hormonal treatment for metastatic disease
boolean
C0279025 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Hormone Therapy | Chemotherapy
Item
concurrent hormonal therapy or chemotherapy
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
fulvestrant
Item
prior fulvestrant therapy
boolean
C0935916 (UMLS CUI [1])
Chemotherapy Regimen Metastatic Neoplasm
Item
more than three prior chemotherapy regimens for metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,2])
Anticoagulation Therapy Long-term
Item
concurrent, long-term anticoagulation therapy
boolean
C0003281 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,2])
Intercurrent disease Severe Uncontrolled
Item
severe, uncontrolled intercurrent illness
boolean
C0277557 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Hypersensitivity Castor Oil
Item
history of hypersensitivity to castor oil
boolean
C0020517 (UMLS CUI [1,1])
C0007343 (UMLS CUI [1,2])
C0007343 (UMLS CUI [1,2])